Pharming Group N.V. (ADR)
General ticker "PHAR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $754.2M (TTM average)
Pharming Group N.V. (ADR) follows the US Stock Market performance with the rate: 54.6%.
Estimated limits based on current volatility of 1.8%: low 17.32$, high 17.95$
Factors to consider:
- Total employees count: 229 as of 2020
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.37$, 21.97$]
- 2026-12-31 to 2027-12-31 estimated range: [11.50$, 20.66$]
Short-term PHAR quotes
Long-term PHAR plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €297.20MM | €377.18MM |
| Operating Expenses | €305.82MM | €357.81MM |
| Operating Income | €-8.62MM | €19.37MM |
| Non-Operating Income | €0.13MM | €-6.49MM |
| Interest Expense | €8.74MM | €21.31MM |
| R&D Expense | €83.15MM | €0.00MM |
| Income(Loss) | €-8.49MM | €12.88MM |
| Taxes | €0.00MM | €10.34MM |
| Profit(Loss)* | €-11.84MM | €2.86MM |
| Stockholders Equity | €221.06MM | €277.02MM |
| Inventory | €55.72MM | €64.88MM |
| Assets | €399.99MM | €499.81MM |
| Operating Cash Flow | €-1.79MM | €50.07MM |
| Capital expenditure | €0.80MM | €0.75MM |
| Investing Cash Flow | €31.62MM | €18.43MM |
| Financing Cash Flow | €-34.41MM | €14.48MM |
| Earnings Per Share** | €-0.17 | €0.04 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.